Vor Biopharma Files Q1 2025 10-Q
Ticker: VOR · Form: 10-Q · Filed: May 14, 2025 · CIK: 1817229
| Field | Detail |
|---|---|
| Company | Vor Biopharma Inc. (VOR) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biopharma
TL;DR
**Vor Biopharma Q1 2025 10-Q filed. Financials and operations update.**
AI Summary
Vor Biopharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quarter of 2025. Key financial data and operational updates are presented within this report.
Why It Matters
This filing provides investors with an update on Vor Biopharma's financial health and operational progress during the first quarter of 2025, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Vor Biopharma faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in 10-Q filings.
Key Numbers
- Q1 2025 — Reporting Period (Covers the first quarter of 2025)
- 2025-03-31 — As of Date (End of the reporting period for financial statements)
Key Players & Entities
- Vor Biopharma Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- 0000950170-25-071349 (accession_number) — Unique identifier for the filing
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is the company's Central Index Key (CIK)?
Vor Biopharma Inc.'s Central Index Key is 0001817229.
What is the Standard Industrial Classification (SIC) code for Vor Biopharma?
The SIC code for Vor Biopharma is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the fiscal year end for Vor Biopharma?
Vor Biopharma's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Vor Biopharma Inc. (VOR).